The discrepancy may have been due to different lupus-prone mouse models used or different activation methods (anti-CD40 versus LPS), although another study has shown that LPS could increase IL-6 production from BMDC of B6.Sle1.Sle2.Sle3 mice [39]. The gene discussed is CD40; the disease is systemic lupus erythematosus.